MYOGENE BIO LLC

MyoGene Bio

MYOGENE BIO LLC is a biotech company in San Diego, United States, founded in 2019. It has raised $7.6M across 5 rounds, most recently a $1.4M Grant in November 2025.

Employees
1–10
Founded
2019
Total Funding
$7.6M
Last Round
$1.4M GrantNov 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.

About

MyoGene Bio develops therapies for muscle diseases, with gene editing as the approach behind its lead program for Duchenne muscular dystrophy. The program is designed to permanently address the underlying cause of the disease. The company plans to develop similar strategies for additional patients and other muscle diseases, aiming to affect disease progression.

Funding History

Data from Indexed.vcUpdated
GrantNov 2025
$1.4M

4 more events

  • Grant2025
  • Grant2025
  • Grant20211 investor

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Companies in related industries

Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech
Corporate RoundTotal funding$1.0BApr 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech
Corporate RoundTotal funding$2.1BJun 2026
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech
Extension RoundTotal funding$1.2BNov 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Biotech
Series ETotal funding$1.1BJun 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MYOGENE BIO LLC on Indexed.vc
<a href="https://indexed.vc/companies/myogene-bio-llc"><img src="https://indexed.vc/api/badge/company/myogene-bio-llc" alt="MYOGENE BIO LLC on Indexed.vc" width="260" height="76" /></a>